男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / The fight against novel coronavirus

Ministry working with researchers on 16 emergency coronavirus projects

By ZHANG ZHIHAO | chinadaily.com.cn | Updated: 2020-02-04 17:54
Share
Share - WeChat

The Ministry of Science and Technology is collaborating with 12 different government agencies and research institutions in five major research areas to tackle the novel coronavirus: investigating its origin and creating drugs, vaccines, animal test models and viral test kits.

Since the outbreak, the ministry has kept a close eye on the situation and launched 16 emergency research projects. At the same time, it has examined existing research projects to find solutions and ideas to combat the virus, Sun Yanrong, deputy director of the ministry's biology center, told a press briefing on Tuesday.

"We have organically combined scientific research with clinical needs and prevention measures to provide effective products and technologies for tackling the epidemic," she said, adding scientists had made considerable progress in the five major research areas.

For example, Chinese scientists swiftly isolated the viral strains and sequenced the virus' whole genome, she said. They are also working on new viral testing kits using immunological technologies to supplement the current kits, which are based on molecular biology.

In terms of medicine, Sun said scientists had selected many pre-existing drugs that may have the potential to inhibit the virus during in vitro experiments, and they are busy testing their safety and potency on lab animals and in clinical trials.

"We will keep conducting systematic research and enhance our international cooperation," she said.

The experimental drug Remdesivir, which had shown exceptional therapeutic capability against the novel coronavirus in one United States patient, would arrive in China for clinical trial on Tuesday afternoon, Sun added, debunking a rumor from Monday that claimed more than 200 patients from Wuhan, Hubei province, had received the medication and their conditions had immediately improved.

On Sunday, Beijing's China-Japan Friendship Hospital said it would begin clinical trials on 270 moderately ill patients infected with the virus in Wuhan using Remdesivir, which was originally developed as an Ebola cure.

The trial has been approved and will run from Monday to April 27, the National Medical Products Administration's Center for Drug Evaluation said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 新和县| 濉溪县| 孝昌县| 蒙山县| 太仆寺旗| 常熟市| 东丰县| 齐河县| 阳东县| 南召县| 长治市| 阿巴嘎旗| 浑源县| 仁化县| 文登市| 遂溪县| 桂平市| 中牟县| 朝阳区| 探索| 九江县| 禹州市| 金华市| 绍兴县| 永靖县| 城口县| 广宗县| 刚察县| 腾冲县| 滕州市| 含山县| 内丘县| 屯昌县| 来安县| 东丽区| 年辖:市辖区| 百色市| 邮箱| 洛阳市| 普兰县| 茌平县|